Past Contest Entries

A new wave of middlemen offers ‘alternative funding’ for specialty drugs. Patients bear the risks

As someone living with cardiac sarcoidosis, 60-year-old Kevin Danahy can’t afford to have bad health insurance. To control the inflammation in his heart, he needs an infusion of Remicade every other month, which he gets at Beth Israel in Boston. The infusion costs thousands of dollars out of pocket, so Danahy typically opts for costly PPO plans for reliable coverage.

Place:

Third Place

Year:

  • 2025

Category:

  • Trade Publications

Affiliation:

Fierce Healthcare

Reporter:

Anastassia Gliadkovskaya